耳鼻咽喉科・頭頸部外科88巻2号

2016年02月発行

特集② がん免疫療法のブレイクスルー—免疫チェックポイント阻害薬

頭頸部がんに対する免疫チェックポイント阻害薬の可能性と現状

著者： 田原信¹ 榎田智弘¹

所属機関： ¹国立がん研究センター東病院頭頸部内科

ページ範囲：P.134 - P.139

文献概要

Point

●頭頸部がんは免疫抑制による疾患である。

●再発・転移頭頸部がんに対しても免疫チェックポイント阻害薬の有効性が示され，現在第Ⅲ相試験が進行中ある。

●免疫療法の今後の展開として，放射線療法との併用が挙げられる。

参考文献

1）Ukpo OC, et al：B7-H1 expression model for immune evasion in human papillomavirus-related oropharyngeal squamous cell carcinoma. Head Neck Pathol 7：113-121 2013

2）Badoual C, et al：PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer. Cancer Res 73：128-138 2013

3）Cho YA, et al：Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma. Oral Oncol 47：1148-1153 2011

4）Hsu MC, et al：Increase of programmed death-1-expressing intratumoral CD8 T cells predicts a poor prognosis for nasopharyngeal carcinoma. Mod Pathol 23：1393-1403, 2010

5）Zhang F, et al：［The clinical significance of the expression of costimulatory molecule PD-L1 in nasopharyngeal carcinoma］. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 22：408-410, 2008

6）Sridharan V：Immune effects of targeted radiation therapy for cancer. Discov Med 19：219-228 2015

7）Cekic C, et al：Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment. Cancer Res 74：7250-7259, 2014

8）Verbrugge I, et al：Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies. Cancer Res 72：3163-3174, 2012

9）Deng L, et al：Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. J Clin Invest 124：687-695 2014

10）Miyamoto Y, et al：Interleukin-6 inhibits radiation induced apoptosis in pancreatic cancer cells. Anticancer Res 21：2449-2456, 2001

11）Zhao L, et al：Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer：a combined analysis from Beijing and Michigan. Int J Radiat Oncol Biol Phys 74：1385-1390, 2009

12）Schroder K, et al：Interferon-gamma：an overview of signals, mechanisms and functions. J Leukoc Biol 75：163-189 2004

13）Kobayashi K, et al：The effect of radiotherapy on NKT cells in patients with advanced head and neck cancer. Cancer Immunol Immunother 59：1503-1509 2010

14）Schmidt MA et al：Circulating regulatory T cells of cancer patients receiving radiochemotherapy may be useful to individualize cancer treatment. Radiother Oncol 104：131-138, 2012

15）Reits EA et al：Radiation modulates the peptide repertoire, enhances MHC class Ⅰ expression, and induces successful antitumor immunotherapy. J Exp Med 203：1259-1271, 2006

16）Garnett CT et al：Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes. Cancer Res 64：7985-7994, 2004

17）Kim JY, et al：Increase of NKG2D ligands and sensitivity to NK cell-mediated cytotoxicity of tumor cells by heat shock and ionizing radiation. Exp Mol Med 38：474-484, 2006

18）Ye J, et al：Recombinant Salmonella-based 4-1BBL vaccine enhances T cell immunity and inhibits the development of colorectal cancer in rats：in vivo effects of vaccine containing 4-1BBL. J Biomed Sci 20：8, 2013